Purdue Pharma case more than an $8B fine

Purdue Pharma

Compliance officers in the pharmaceutical and healthcare industries should look beyond the $8 billion fine Purdue Pharma received from the DOJ and at the bigger enforcement trend highlighting the need for better oversight in the field.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.